Shock clinical trials at UCSF
1 research study open to eligible people
Shock is a condition where the body cannot get enough blood flow. UCSF is studying how different fluids affect children with sepsis. These trials help find the safest and most effective treatments.
Showing trials for
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
open to eligible people ages 2 months to 17 years
The objectives of this multicenter pragmatic clinical trial are to compare the effectiveness and relative safety of balanced fluid resuscitation versus 0.9% "normal" saline in children with septic shock, including whether balanced fluid resuscitation can reduce progression of kidney injury.
San Francisco, California and other locations
Our lead scientists for Shock research studies include Karim Mansour, MD.
Last updated: